Dyssynergia Cerebellaris Myoclonica

What is dyssynergia cerebellaris myoclonica?

Dyssynergia cerebellaris myoclonica refers to a group of rare, degenerative, neurological disorders characterized by:

  • Epilepsy
  • Cognitive impairment
  • Myoclonus (brief, involuntary twitching or jerking of a muscle)
  • Progressive ataxia (problems with balance and coordination)

Symptoms include:

  • Seizures
  • Tremor
  • Reduced muscle coordination

The disorder generally begins in early adulthood. Tremor may begin in one limb and later spread to involve the entire voluntary muscular system. Arms are usually more affected than legs. Some cases are due to mitochondrial abnormalities. Treatment is symptomatic. The progression of the disorder is usually 10 years or longer.

file-medical
Learn About Clinical Trials
Clinical trials are studies that allow us to learn more about disorders and improve care. They can help connect patients with new and upcoming treatment options.

How can I or my loved one help improve care for people with dyssynergia cerebellaris myoclonica?

Consider participating in a clinical trial so clinicians and scientists can learn more about dyssynergia cerebellaris myoclonica and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease.

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them.

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with dyssynergia cerebellaris myoclonica at Clinicaltrials.gov.

Where can I find more information on dyssynergia cerebellaris myoclonica?

Information may be available from the following organizations: